Klue, a digital health company focused on behavior tracking and positive change, announces today it plans to expand its platform to type 1 diabetes. The start-up is known for its gesture sensing and analytics technology that promotes mindful eating and proper hydration. Now, the company aims to use patented technology to create "never-seen-before" capabilities in the realm of treating type 1 diabetes. By using software, it plans to unlock solutions that will be life-changing for patients who have had a lifetime of daily injections and blood sugar monitoring. Klue's fine motor artificial intelligence technology detects high impact moments and allows individuals to better manage their health, all based on insights that are captured automatically from analyzing their wrist movements.